| Bioactivity | D-Galactose pentaacetate inhibits leucine-induced insulin release. D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2]. |
| CAS | 25878-60-8 |
| Formula | C16H22O11 |
| Molar Mass | 390.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. W J Malaisse, et al. Inhibition of insulin release by alpha- and beta-D-galactose pentaacetate. Int J Mol Med. 1998 Sep;2(3):331-2. [2]. M M Kadiata, et al. Opposite effects of D-glucose pentaacetate and D-galactose pentaacetate anomers on insulin release evoked by succinic acid dimethyl ester in rat pancreatic islets. Life Sci. 1999;64(9):751-4. |
D-Galactose pentaacetate
CAS: 25878-60-8 F: C16H22O11 W: 390.34
D-Galactose pentaacetate inhibits leucine-induced insulin release. D-Galactose pentaacetate can be used for the research
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.